CD274 and mesothelioma: Prior preclinical work has demonstrated variability with PD-L1 expression under the stress of cytotoxic chemotherapy in mesothelioma cell lines.13 These observations raise additional considerations in the context of this measurement of clinically variable PD-L1 expression.